Brachytherapy benefits patients with anal cancer, study finds

04/26/2013 | Medscape (free registration)

A brachytherapy boost benefits patients with anal cancer who have had radiotherapy with or without chemotherapy, French researchers report. The study found patients receiving a brachytherapy boost had better control and few toxic side effects and that local efficacy was a strong predictor of survival.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY